164 related articles for article (PubMed ID: 33730427)
21. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
Moore T; Lee AH
Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
[TBL] [Abstract][Full Text] [Related]
22. Accuracy and clinical implications of pre-operative breast core needle biopsy diagnoses of fibroepithelial neoplasms and sarcomatoid carcinomas.
Ware AD; Argani P; Cimino-Mathews A
Breast Cancer Res Treat; 2019 Nov; 178(1):51-56. PubMed ID: 31332664
[TBL] [Abstract][Full Text] [Related]
23. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis.
Ahmed SS; Lim JCT; Thike AA; Iqbal J; Tan PH
J Clin Pathol; 2022 May; 75(5):316-323. PubMed ID: 33627375
[TBL] [Abstract][Full Text] [Related]
25. Spindle cell tumours of the breast: practical approach to diagnosis.
Al-Nafussi A
Histopathology; 1999 Jul; 35(1):1-13. PubMed ID: 10383708
[TBL] [Abstract][Full Text] [Related]
26. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
[TBL] [Abstract][Full Text] [Related]
27. High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates.
Yoon E; Ding Q; Hunt K; Sahin A
Surg Pathol Clin; 2022 Mar; 15(1):77-93. PubMed ID: 35236635
[TBL] [Abstract][Full Text] [Related]
28. An algorithmic approach to spindle cell lesions of the breast.
Varma S; Shin SJ
Adv Anat Pathol; 2013 Mar; 20(2):95-109. PubMed ID: 23399795
[TBL] [Abstract][Full Text] [Related]
29. [Metaplastic spindle-cell (fibromatosis-like) carcinoma of the breast--report of 4 cases].
Kinkor Z; Svitáková I; Ryska A; Kodet R; Hrabal P
Cesk Patol; 2002 Oct; 38(4):164-8. PubMed ID: 12629863
[TBL] [Abstract][Full Text] [Related]
30. Rare case of biphasic tumor of the breast with prominent CD34-positive spindle cells.
Hayashi M; Tamura G; Matsumoto O; Motoyama T
Pathol Int; 2001 Sep; 51(9):713-7. PubMed ID: 11696175
[TBL] [Abstract][Full Text] [Related]
31. Myofibroblastic, fibroblastic and myoid lesions of the breast.
Krings G; McIntire P; Shin SJ
Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104
[TBL] [Abstract][Full Text] [Related]
32. Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights.
Rungta S; Kleer CG
Arch Pathol Lab Med; 2012 Aug; 136(8):896-900. PubMed ID: 22849737
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy.
Sasaki M; Sato Y
Virchows Arch; 2021 Oct; 479(4):697-703. PubMed ID: 34115196
[TBL] [Abstract][Full Text] [Related]
34. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
Korula A; Varghese J; Thomas M; Vyas F; Korula A
Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
[TBL] [Abstract][Full Text] [Related]
35. A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma.
Yeong J; Thike AA; Young Ng CC; Md Nasir ND; Loh K; Teh BT; Tan PH
Pathology; 2017 Dec; 49(7):786-789. PubMed ID: 29066183
[No Abstract] [Full Text] [Related]
36. Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes.
McMullen ER; Skala SL; Gonzalez ME; Djomehri S; Chandrashekar DS; Varambally S; Kleer CG
Breast Cancer; 2021 Mar; 28(2):496-505. PubMed ID: 33247371
[TBL] [Abstract][Full Text] [Related]
37. EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
Guo S; Li X; Rohr J; Wang Y; Ma S; Chen P; Wang Z
Diagn Pathol; 2016 Apr; 11():41. PubMed ID: 27113214
[TBL] [Abstract][Full Text] [Related]
38. Spindle cell lesions of the breast--the pathologic differential diagnosis.
Tse GM; Tan PH; Lui PC; Putti TC
Breast Cancer Res Treat; 2008 May; 109(2):199-207. PubMed ID: 17636400
[TBL] [Abstract][Full Text] [Related]
39. Recurrent angio-fibroma of breast masquerading as phyllodes tumor.
Chaurasia JK; Alam F; Shadan M; Naim M
J Cancer Res Ther; 2015; 11(3):650. PubMed ID: 26458623
[TBL] [Abstract][Full Text] [Related]
40. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
